Genetic Predisposition and Environmental Factors in Endometriosis
New research suggests that a combination of ancient genetic predispositions and exposure to modern environmental chemicals may increase a woman’s likelihood of developing endometriosis. This significant finding, published in the journal *European Journal of Human Genetics*, highlights the complex interplay between our inherited DNA and contemporary environmental influences on the condition. Around one in ten women of reproductive age worldwide are affected by endometriosis, a chronic gynecological disorder characterized by severe pain and inflammation, often linked to immune system dysfunction.
The study, led by Amelia Warren during her master’s degree at Bournemouth University, points to the challenges in early diagnosis and treatment of endometriosis. Warren noted that routine diagnostic methods like ultrasounds often miss early markers, and pelvic pain, a common symptom, is frequently dismissed as a normal part of menstruation, leading to diagnoses only in severe cases.
Key Study Findings
Researchers initiated their investigation by reviewing existing literature to pinpoint five genes strongly associated with endometriosis. These genes were also identified as particularly susceptible to prevalent modern chemicals known to interfere with hormones and disrupt the immune system. Utilizing data from the NHS’s Genomics England database, the team analyzed genetic variations in 19 women diagnosed with endometriosis, comparing them to women without the condition. They discovered six genetic variants that appeared more frequently in women with endometriosis. Notably, some of these variations seem to have been passed down from early human ancestors, including Neanderthals.
A crucial aspect of these findings is that several identified genetic variations are located in genes known to react to chemicals previously considered safe. These chemicals are now commonly found in plastics, cosmetics, and various household products. The research team proposes that the interaction between these inherited genetic traits and exposure to such chemicals could disrupt the body’s immune system, potentially leading to the inflammation characteristic of endometriosis. This understanding opens avenues for identifying individuals at higher risk of developing the disease earlier.
Expert Commentary and Public Health Implications
Dr. Anna Mantzouratou, a Visiting Fellow at Bournemouth University who supervised the research, emphasized that while these genetic variants have long been a part of the human genome, the modern chemical environment is relatively new. She stated that understanding how these interactions influence conditions like endometriosis is a vital step. “If we can better understand how environmental exposures ‘activate’ or influence these biological processes, we may be able to identify risk earlier and support women long before symptoms become severe,” Dr. Mantzouratou explained. This research is crucial for providing a more accurate understanding of endometriosis and can potentially lead to earlier diagnosis and more personalized treatments, addressing a condition that affects a significant portion of women globally, as highlighted by Wellbeing of Women UK.
Historically, research into women’s reproductive health conditions like endometriosis has been underfunded. However, studies like this offer a foundation for developing novel therapeutic approaches, including the repurposing of existing drugs or the creation of combined treatments for endometriosis and related immunological conditions. The results also advocate for closer monitoring of women with endometriosis for the development of immunological conditions, as early detection can significantly improve patient outcomes. For additional context on how genetic information can advance understanding of various health conditions, readers can find more information on ox.ac.uk.
Next Steps in Research and Patient Care
The research team aims to explore potential therapeutic strategies that can simultaneously address both endometriosis and its associated immune conditions. Future studies will focus on identifying biomarkers, conducting clinical trials, and developing targeted treatment options to translate these genetic and phenotypic associations into tangible healthcare solutions. The long-term goal is to improve patient outcomes by enabling earlier intervention and more effective management of this debilitating condition. Furthermore, a broad, multi-ancestry study involving data from over 900,000 women has significantly expanded the genetic landscape of endometriosis, identifying 45 significant loci, including seven previously unreported ones, and highlighting critical roles of immunopathogenesis and hormone signaling pathways [medrxiv.org](https://www.medrxiv.org/content/10.1101/2024.11.26.24316723v1.full).
